AllianzGI Health Sciences A (RAGHX)
* As of 31-Jan-16
Quotes delayed, except where indicated otherwise. Currency in USD.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||1.46%|
Performance & Risk
|5y Avg Return:||15.16%|
|Rank in Category (ytd):||34|
|% Rank in Category (ytd):||26.36%|
|Morningstar Risk Rating:||3|
The investment seeks long-term capital appreciation.
The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio managers consider health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences or that otherwise promote healthy living. The fund will invest primarily in common stocks and other equity securities. View More